As Deputy Director General and Chief Operating Officer, Fumie leads IFPMA’s strategic planning process and international engagement on a range of global health topics from pandemic preparedness to universal health coverage.

She is an internationally recognized expert on health policy and economics and has served on the Expert Review Committee for the Access to Medicine Index since 2017.

Before joining IFPMA, Fumie was Head of Global Oncology Policy and Strategy, Global Government Affairs & Policy at Merck KGaA and Vice President for International Health Policy at Pharmaceutical Research and Manufacturers of America (PhRMA). Prior to joining the innovative pharmaceutical industry, she served as a senior economist in the White House’s Office of Management and Budget, where she provided policy advice to senior policy officials in both the Bush and Obama Administrations.

Fumie has a PhD in Health Policy from Harvard University and Bachelor and Master of Science degrees in Earth Systems (concentration on environmental economics and policy) from Stanford University.

At IFPMA, we are dedicated to building bridges between the industry and global health stakeholders, identifying common ground and offering a solutions-oriented action plan where the industry can contribute to the overall global health agenda.